eGenesis Company
Xenotransplant
Investors
Headquarters:
USA
Total Funding:
$265.00
Last Funding Type:
Series C
Founded Date:
2014
Estimated Revenue:
$10M to $50M
Industry:
Risk Mitigation
Investor Type:
Late Stage Venture
Last Funding Date:
2021
Investors Number:
27
Employee Number:
11-50